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ABSTRACT
Tinospora crispa is a traditional medicinal plant in Malaysia with anti-cancer properties 
as shown in recent studies. The main objective of this study was to determine the anti­
proliferative effect of T. crispa methanol extract on triple negative breast cancer. MTT 
assay was performed to determine the cell viability of triple negative breast cancer cell 
lines (MDA-MB-231 and HCC1806) and normal breast cell line (MCF-10A). The type of 
cell death was determined using flow cytometry and cellular DNA fragmentation ELISA 
while Comet assay was used to determine the genotoxicity. qPCR was used to investigate 
the mRNA expression levels of the caspases 3, 8, 9 and NF-kB. The present results 
showed that T. crispa decreased the cell viability in triple negative breast cancer cells in a 
dose dependent manner with an IC50 of 66±3/ag/ml and 60±4|ig/ml in MDA-MB-231 and 
HCC1806 cells respectively. While for MCF-10A, the IC50 was 248±4(rg/ml. The type of 
cell death in MDA-MB-231, HCC1806 and MCF-10A cells was mainly due to apoptosis. 
The comet assay data for T. crispa did not detect any DNA damage on MDA-MB-231, 
HCC1806 and MCF-10A cell lines. Our results also showed that cisplatin significantly 
up-regulated NF-kB gene expression. Many studies reported that the up-regulation of NF- 
kB increases the resistance of cancer cells to apoptosis. Unlike cisplatin, T. crispa did not 
show any significant change in the mRNA expression levels of NF-kB. Furthermore, 
when used in combination T. crispa and cisplatin, the combination significantly down- 
regulated the gene expression of NF-kB and significantly up-regulated the gene 
expression of caspases 3, 8 and 9 in the cancer cells compared to single usage indicating 
more apoptotic activity. In Conclusion, T. crispa showed anti-proliferative effect on triple 
negative breast cancer cells with less toxicity to the normal breast cells. The cell death 
was mainly due to apoptosis and the combination of T. crispa and cisplatin significantly 
down-regulated the NF-kB gene expression which in turn increased apoptosis in the 
cancer cell lines.
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CHAPTER ONE 
INTRODUCTION
1.1 OVERVIEW
Triple negative breast cancer (TNBC) is a subtype of breast cancer that accounts 
for approximately 15% - 20% of breast cancer cases. TNBC is negative for expression of 
progesterone receptor (PR), oestrogen receptor (ER) and erythroblastic leukaemia viral 
oncogene homolog 2 (ErbB2) [also known as human epidermal growth factor receptor 2 
(HER2)]. It is characterized by its aggressive behaviour, unique molecular profile, lack of 
targeted therapies and distinct pattern of metastasis [1]. The pattern of metastasis of 
TNBC is more directed to an orderly progression from the primary site to the regional 
lymph node or the sentinel lymph node in the majority of cases with subsequent 
dissemination to the systemic sites. TNBC have higher tendency of visceral metastasis as 
compared to other types of breast cancer. This may be explained in part by altering the 
expression of Epidermal Growth Factor Receptor (EGFR) which in turn promotes 
aggressive pattern of metastasis in TNBC cells [2, 3].
Several studies showed the efficacy of cisplatin in treatment of TNBC [4-6]. 
Strategies to optimize the existing chemotherapy treatments have the potential to 
consolidate chemo-sensitivity and decrease their side effects. Recent studies suggested 
that a combined therapy using plant extracts and cisplatin can improve the anti­
proliferative activity and reduce the side effects of cisplatin in several types of cancers [7-
9]-
Cancer chemotherapeutic agents can often provide prolongation of life, temporary 
relief from symptoms and occasionally, cures. An efficient chemotherapeutic agent 
should incapacitate or kill cancerous cells without causing unnecessary damage to the 
normal cells. Inducing apoptosis in cancerous cells could accomplish this ideal condition 
since apoptosis only involves one cell and it will not lead to inflammation, destruction, or 
scarring and fibrosis of adjacent tissues. The existence of both cancer and normal cells is 
considerably affected by the rate of apoptosis [10]. Therefore, modulating apoptosis may 
be valuable in the prevention or healing of cancer.
